Cargando…

Nonclassical roles for IFN-γ and IL-10 in a murine model of immunoedition

AIM: To characterize, by means of univariate and multivariate approaches, the T helper (Th)-1 and Th-2 responses during the different phases of tumor immunoediting. MATERIALS & METHODS: We used a multivariate principal component analysis applied to analyze the joint behavior of serum concentrati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giúdice, Antonela Del, Pagura, Lucas, Capitani, María Celeste, Mainetti, Leandro Ernesto, Scharovsky, O Graciela, Di Masso, Ricardo José, Rico, María José, Rozados, Viviana Rosa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Science Ltd 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720370/ https://www.ncbi.nlm.nih.gov/pubmed/33312693 http://dx.doi.org/10.2144/fsoa-2019-0108

Ejemplares similares

A mammary adenocarcinoma murine model suitable for the study of cancer immunoediting
por: Pagura, Lucas, et al.
Publicado: (2014)

Losartan improves the therapeutic effect of metronomic cyclophosphamide in triple negative mammary cancer models
por: Mainetti, Leandro E., et al.
Publicado: (2020)

Cancer stem cell immunoediting by IFNγ
por: Galassi, Claudia, et al.
Publicado: (2023)

IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting
por: Takeda, Kazuyoshi, et al.
Publicado: (2017)

Metronomic chemotherapy: changing the paradigm that more is better
por: Scharovsky, O.G., et al.
Publicado: (2009)

Antitumor activity of new chemical compounds in triple negative mammary adenocarcinoma models
por: Giolito, María V, et al.
Publicado: (2020)

Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
por: Perroud, Herman Andrés, et al.
Publicado: (2017)

Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27–28 May, 2016, Rosario, Argentina
por: Rosé, Adriana, et al.
Publicado: (2016)

Metformin and propranolol combination prevents cancer progression and metastasis in different breast cancer models
por: Rico, María, et al.
Publicado: (2016)

Lessons from Cancer Immunoediting in Cutaneous Melanoma
por: Aris, Mariana, et al.
Publicado: (2012)

Melanoma immunoediting by NK cells
por: Balsamo, Mirna, et al.
Publicado: (2012)

Exosomes in cancer immunoediting and immunotherapy
por: Zhao, Yarong, et al.
Publicado: (2022)

Cancer Immunoediting and beyond in 2021
por: Borroni, Elena Monica, et al.
Publicado: (2021)

Immunotherapy for liver tumors: present status and future prospects
por: Matar, Pablo, et al.
Publicado: (2009)

Cancer immunoediting: A game theoretical approach
por: Tavakoli, Fatemeh, et al.
Publicado: (2021)

Nonclassical Recrystallization
por: Brunner, Julian, et al.
Publicado: (2020)

Expression of tumour-specific antigens underlies cancer immunoediting
por: DuPage, Michel, et al.
Publicado: (2012)

Have Cells Harboring the HIV Reservoir Been Immunoedited?
por: Huang, Szu-Han, et al.
Publicado: (2019)

Immunosurveillance and Immunoediting of Lung Cancer: Current Perspectives and Challenges
por: Kunimasa, Kei, et al.
Publicado: (2020)

Neoantigen quality predicts immunoediting in survivors of pancreatic cancer
por: Łuksza, Marta, et al.
Publicado: (2022)

Cancer immunoediting hypothesis: history, clinical implications and controversies
por: Lasek, Witold
Publicado: (2022)

Novel strategies for cancer immunotherapy: counter-immunoediting therapy
por: Liu, Shaochuan, et al.
Publicado: (2023)

Potential effect of chloroquine and propranolol combination to treat colorectal and triple-negative breast cancers
por: Anselmino, L. E., et al.
Publicado: (2023)

Immunoediting is not a primary transformation event in a murine model of MLL-ENL AML
por: Dudenhöffer-Pfeifer, Monika, et al.
Publicado: (2018)

Cancer immunoediting by the innate immune system in the absence of adaptive immunity
por: O’Sullivan, Timothy, et al.
Publicado: (2012)

A proposed role for neutrophil extracellular traps in cancer immunoediting
por: Berger-Achituv, Sivan, et al.
Publicado: (2013)

The Janus Face of Death Receptor Signaling during Tumor Immunoediting
por: O’ Reilly, Eimear, et al.
Publicado: (2016)

HTLV-1 as a Model for Virus and Host Coordinated Immunoediting
por: Mota, Talia M., et al.
Publicado: (2019)

Gene essentiality for tumour growth influences neoantigen‐directed immunoediting
por: Bang, Hyoeun, et al.
Publicado: (2022)

Tumor-Derived Extracellular Vesicles in Cancer Immunoediting and Their Potential as Oncoimmunotherapeutics
por: Najaflou, Meysam, et al.
Publicado: (2022)

Theory of nonclassical states of light /
Publicado: (2003)

Nonclassical Vitamin D Action
por: Zittermann, Armin, et al.
Publicado: (2010)

Nonclassic Congenital Adrenal Hyperplasia
por: Witchel, Selma Feldman, et al.
Publicado: (2010)

Nonclassically Secreted Regulators of Angiogenesis
por: Prudovsky, Igor
Publicado: (2013)

Quantifying the nonclassicality of pure dephasing
por: Chen, Hong-Bin, et al.
Publicado: (2019)

Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution
por: Efremova, Mirjana, et al.
Publicado: (2018)

Glioma immunoediting, a driver of tumor evolution, and the next battle for immunotherapy
por: Sonabend, Adam M., et al.
Publicado: (2021)

The Spatial Landscape of Progression and Immunoediting in Primary Melanoma at Single-Cell Resolution
por: Nirmal, Ajit J., et al.
Publicado: (2022)

MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma
por: Gramantieri, Laura, et al.
Publicado: (2022)

Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity
por: Houlahan, Kathleen E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rrjneo5h5hgnfa8rh588537295